Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension.

Yeager ME, Nguyen CM, Belchenko DD, Colvin KL, Takatsuki S, Ivy DD, Stenmark KR.

Chest. 2012 Apr;141(4):944-952. doi: 10.1378/chest.11-0205. Epub 2011 Sep 22.

2.

Myeloid-derived suppressor cells in breast cancer.

Markowitz J, Wesolowski R, Papenfuss T, Brooks TR, Carson WE 3rd.

Breast Cancer Res Treat. 2013 Jul;140(1):13-21. doi: 10.1007/s10549-013-2618-7. Epub 2013 Jul 5. Review.

3.

Complexity and challenges in defining myeloid-derived suppressor cells.

Damuzzo V, Pinton L, Desantis G, Solito S, Marigo I, Bronte V, Mandruzzato S.

Cytometry B Clin Cytom. 2015 Mar;88(2):77-91. doi: 10.1002/cyto.b.21206. Epub 2014 Dec 12. Review.

4.

Myeloid-derived suppressor cells in the inflammatory bowel diseases.

Ostanin DV, Bhattacharya D.

Inflamm Bowel Dis. 2013 Oct;19(11):2468-77. doi: 10.1097/MIB.0b013e3182902b11. Review.

PMID:
23811636
5.

Myeloid-derived suppressor cells in immunity and autoimmunity.

Yang H, Bi Y, Han F, Lu Y, Wang J, Zhang Z, Liu G.

Expert Rev Clin Immunol. 2015;11(8):911-9. doi: 10.1586/1744666X.2015.1052794. Epub 2015 May 31. Review.

PMID:
26028421
6.

Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

Parker KH, Beury DW, Ostrand-Rosenberg S.

Adv Cancer Res. 2015;128:95-139. doi: 10.1016/bs.acr.2015.04.002. Epub 2015 May 12. Review.

7.

Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases.

Kwak Y, Kim HE, Park SG.

Arch Immunol Ther Exp (Warsz). 2015 Aug;63(4):269-85. doi: 10.1007/s00005-015-0342-1. Epub 2015 May 20. Review.

PMID:
25990434

Supplemental Content

Support Center